If you’re going to clarify that no immediate income will be generated. You could perhaps clarify the number of cells to be ‘given’ for testing. For Clarity, you could include whether LIS has this number of test cells on the shelf, if not expected lead time. Publishing test parameters would not hurt either.
If you’re going to clarify that no immediate income will be...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.010(5.88%) |
Mkt cap ! $115.2M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.5¢ | 16.5¢ | $186.5K | 1.046M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 95266 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 798425 | 6 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| LIS (ASX) Chart |